arrow_back Back to App

Tax Credits for US-Made Medicine and Medical Equipment

This bill creates new tax credits for companies that manufacture medicines, pharmaceutical ingredients, and medical equipment within the United States. The aim is to encourage bringing medical production back to the country. Additional credits are available for investing in advanced manufacturing equipment and equipment used to meet environmental standards.
Key points
Companies manufacturing medicines and certain countermeasures in the US can receive a tax credit based on income from this activity.
A tax credit is available for investing in advanced equipment to manufacture drugs, medical devices, and biological products in the US.
The bill provides a tax credit for equipment used in US medical manufacturing to meet clean air and water standards.
The amount of equipment credits will gradually decrease from 2029-2030 and expire after 2030.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_7410
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
Process start date: 2022-04-05